Mobile Menu

Search Results

Search results for: Pancreatic Cancer

Novel nanoparticle-based chemoimmunotherapy shrinks tumours in mice

Researchers have developed a nanoparticle-based approach to overcome the immunosuppressive microenvironment of tumours. The study, published in Nature Nanotechnology, detailed […]

Genomics week in brief: Week ending 1st July

Check out the latest Genomics Week in Brief – full of intriguing news and research from the genomics space! Top […]

Patient Perspectives: Peter Coleman, Independent Researcher and Full-time Carer

Peter Coleman is an independent researcher and full-time carer with a background in sound, TV, film and special effects. Both […]

Molecular Biomarkers ONLINE – Webinar Series

The discovery and classification of molecular biomarkers and diagnostics is holding promise for the effective delivery of precision medicine. With […]

Patient Perspectives: Caroline Presho – Director of BRCA Umbrella

Caroline Presho is a mother, motivational speaker and Director of the online platform, BRCA Umbrella. After testing positive for a […]

Liquid Biopsy ONLINE 2021 Webinar Series

One of the most exciting applications of cancer genomics is the development of liquid biopsies. Measuring circulating tumour cells or cell-free […]

A new strategy to combat solid tumours with neoantigen-based immunotherapy

A preclinical study has provided in vitro and in vivo evidence for using mutated KRAS epitopes as a viable target […]

Genomics week in brief: Week ending 1st May

We have collated all the latest genomics new and research and put it here for you to easily read! Top […]

Interview with Dr Susie Cooke, Head of Medical Genomics at the Glasgow Precision Oncology Laboratory

Dr Susie Cooke is the Head of Medical Genomics at the Glasgow Precision Oncology Laboratory whose main interest is in facilitating the move of next-generation sequencing into the clinic to help cancer patients.

Arming CAR-T cells to fight solid tumours

Written by Charlotte Harrison, Science Writer  Immunotherapy with chimeric antigen receptor T cells (CAR-T cells) has yielded impressive anticancer responses […]